Error: Could not add to watchlist. X

Credit Suisse Lux Global Biotech Innovators Equity Fund

+ Watchlist
CR4A:SW
SIX Swiss Ex
325.60
USD
0.00
0.00%
As of 11:43 AM EST on 2/10/2016.
Open
325.60
Previous Close
325.60
52Wk Range
436.40 - 514.50
1 Yr Return
-25.15%
YTD Return
-28.41%
Open
325.60
Volume
0
Previous Close
325.60
52Wk Range
436.40 - 514.50
1 Yr Return
-25.01%
YTD Return
-28.41%
NAV (on -)
-
Total Assets (m USD) (on 02/09/2016)
157.752
Inception Date
-
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
IRENE BEATRICE PUETTNER
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
2.19%
3 Mo Return
-28.11%
3 Yr Return
-
5 Yr Return
-
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 172.48 k 18.28 m 7.81
Amgen Inc 100.97 k 16.27 m 6.95
Celgene Corp 140.28 k 15.35 m 6.56
Biogen Inc 52.00 k 14.92 m 6.38
Regeneron Pharmaceuticals Inc 24.00 k 13.07 m 5.59
Vertex Pharmaceuticals Inc 85.00 k 11.00 m 4.70
Incyte Corp 95.00 k 10.85 m 4.64
Alexion Pharmaceuticals Inc 60.75 k 10.84 m 4.63
BioMarin Pharmaceutical Inc 95.44 k 9.10 m 3.89
Alkermes PLC 100.00 k 7.34 m 3.14
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
ADDRESS
Credit Suisse AG
PHONE
-